Consilio Wealth Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Consilio Wealth Advisors’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90,199	Closed	-$10K	–	50
2022 Q4	$10K	Sell	90,199 -7,319	-8%	-$4.67K	0.01%	48
2022 Q3	$103K	Hold	97,518	–	–	0.08%	45
2022 Q2	$181K	Hold	97,518	–	–	0.15%	35
2022 Q1	$348K	Hold	97,518	–	–	0.27%	35
2021 Q4	$840K	Buy	+97,518	New	+$620K	0.65%	28

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Consilio Wealth Advisors's LHDX Position: Q1 2023 in Review

Consilio Wealth Advisors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 90,199 shares — an estimated $10K sold.

Consilio Wealth Advisors first reported a position in LHDX in Q4 2021 and held it in 5 quarters. The position peaked at $840K in Q4 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Consilio Wealth Advisors reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Consilio Wealth Advisors sold 90,199 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $10K.
Consilio Wealth Advisors first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Consilio Wealth Advisors's Lucira Health, Inc. Common Stock position peaked at $840K in Q4 2021.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Consilio Wealth Advisors's 13F filing for Q1 2023, filed 6 Apr 2023.